The Pharmacoeconomics of ACE Inhibitors in Chronic Heart Failure
- 1 March 1996
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 9 (3) , 188-197
- https://doi.org/10.2165/00019053-199609030-00002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Costs and effects of enalapril therapy in patients with symptomatic heart failure: An economic analysis of the studies of left ventricular dysfunction (SOLVD) treatment trialJournal of Cardiac Failure, 1995
- Epidemiology of heart failure in the United StatesAmerican Heart Journal, 1993
- Spectrum and outcome of congestive heart failure in a hospitalized populationAmerican Heart Journal, 1993
- Trends in hospitalization for heart failure in Scotland 1980-1990European Heart Journal, 1993
- The Beaver Dam Health Outcomes studyMedical Decision Making, 1993
- Effects of ACE Inhibitors on Heart Failure in The NetherlandsPharmacoEconomics, 1993
- Prevalence and mortality rate of congestive heart failure in the United StatesJournal of the American College of Cardiology, 1992
- Tolerability of enalapril in congestive heart failureThe American Journal of Cardiology, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986